211 related articles for article (PubMed ID: 16944027)
1. Combined gemcitabine and alpha-interferon therapy for pancreatic cancer: report of a case.
Sawai H; Okada Y; Tanaka M; Funahashi H; Yamamoto M; Takeyama H; Manabe T
Dig Dis Sci; 2006 Jul; 51(7):1285-9. PubMed ID: 16944027
[No Abstract] [Full Text] [Related]
2. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Kourie HR; Gharios J; Kattan J
Future Oncol; 2017 Feb; 13(3):197-199. PubMed ID: 27624286
[No Abstract] [Full Text] [Related]
3. Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy.
An X; Li YH; Lin XB; Wang FH; Feng F; Xu RH; Jiang WQ; He YJ
Ai Zheng; 2009 Mar; 28(3):286-91. PubMed ID: 19619444
[TBL] [Abstract][Full Text] [Related]
4. [Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer].
Dahan L; Ressiot E; Cournede A; Ries P; Duluc M; Laquiere A; Laugier R; Braguer D; Seitz JF
Gastroenterol Clin Biol; 2007 Dec; 31(12):1143-5. PubMed ID: 18176375
[TBL] [Abstract][Full Text] [Related]
5. Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine.
Ciotti R; Belotti G; Facchi E; Cantù A; D'Amico A; Gatti C
Ann Oncol; 1999 Aug; 10(8):997. PubMed ID: 10509166
[No Abstract] [Full Text] [Related]
6. Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer.
Boeck S; Heinemann V
J Clin Oncol; 2008 Mar; 26(7):1178-9; author reply 1179. PubMed ID: 18309957
[No Abstract] [Full Text] [Related]
7. A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.
El-Rayes BF; Zalupski MM; Shields AF; Ferris AM; Vaishampayan U; Heilbrun LK; Venkatramanamoorthy R; Adsay V; Philip PA
Invest New Drugs; 2005 Dec; 23(6):583-90. PubMed ID: 16034525
[TBL] [Abstract][Full Text] [Related]
8. [A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases].
Kimura H; Fushida S; Mukawa A
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1191-4. PubMed ID: 19620816
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.
Cunningham SC; Cusnir M; Burdick RK; Van Echo DA; Moesinger R
Clin Adv Hematol Oncol; 2003 Dec; 1(12):741-2; discussion 743. PubMed ID: 16258479
[No Abstract] [Full Text] [Related]
10. Icotinib plus gemcitabine for metastatic pancreatic cancer: a case report.
Zhao J; Shen H; Hu HG; Huang JJ
World J Gastroenterol; 2015 Mar; 21(11):3441-6. PubMed ID: 25805958
[TBL] [Abstract][Full Text] [Related]
11. [Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy].
Suda H; Omori K; Suematsu Y; Hiratsuka M; Takahashi M; Saito H; Ishibashi Y; Morita A; Wakabayashi K; Ito Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2388-90. PubMed ID: 26805373
[TBL] [Abstract][Full Text] [Related]
12. Inoperable pancreatic adenocarcinoma rendered complete remission by high-intensity focused ultrasound concurrent with gemcitabine-capecitabine chemotherapy: case report and topic review.
Lau PC; Zheng SF; Ng WT; Yu SC
J Dig Dis; 2012 Jan; 13(1):60-4. PubMed ID: 22188918
[No Abstract] [Full Text] [Related]
13. [Non-small cell lung cancer with liver metastasis responsive to gemcitabine--a case report].
Sakurai T; Oura S; Yoshimasu T; Tanino H; Kokawa Y; Nakamura T; Matsuyama K; Naito Y
Gan To Kagaku Ryoho; 2001 May; 28(5):707-10. PubMed ID: 11383223
[TBL] [Abstract][Full Text] [Related]
14. Novel approaches to postoperative chemoradiation therapy in pancreatic cancer.
Picozzi VJ
J Gastrointest Surg; 2001; 5(1):8-9. PubMed ID: 11370619
[No Abstract] [Full Text] [Related]
15. [A case of pancreatic body cancer with multiple liver metastases experiencing long-term response by gemcitabine plus erlotinib therapy].
Ohkawa S; Sakamoto Y; Ueno M
Gan To Kagaku Ryoho; 2013 Jun; 40(6):785-8. PubMed ID: 23863659
[TBL] [Abstract][Full Text] [Related]
16. Advanced Pancreatic Adenocarcinoma: Complete Histological Response After Palliative Therapy with Gemcitabine and Cisplatin.
Alexander A; Rehders A; Riediger R; Schmitt M; Anlauf M; Knoefel WT
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S42-5. PubMed ID: 22528322
[No Abstract] [Full Text] [Related]
17. Gemcitabine plus cisplatin in advanced pancreatic cancer.
McWilliams RR; Alberts SR
J Clin Oncol; 2007 Mar; 25(9):1142; author reply 1142-3. PubMed ID: 17369580
[No Abstract] [Full Text] [Related]
18. Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab-paclitaxel in pancreatic cancer.
Zhang Z; Ji S; Hu Q; Zhuo Q; Liu W; Xu W; Liu W; Liu M; Ye Z; Fan G; Xu X; Yu X; Qin Y
Clin Transl Med; 2021 Aug; 11(8):e398. PubMed ID: 34459132
[No Abstract] [Full Text] [Related]
19. Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
Cao C; Kuang M; Xu W; Zhang X; Chen J; Tang C
Jpn J Clin Oncol; 2015 Dec; 45(12):1122-30. PubMed ID: 26518328
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
Rocha Lima CM; Flores AM
J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
